USPTO serial 97621865
BLUESIGHT
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 23, 2026
- Examiner
- SINGH, TEJBIR
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BLUESIGHT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ALEXANDRIA, VA, US
Alexandria, VA, US
ALEXANDRIA, VA, US
ALEXANDRIA, VA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
GREGORY B. PHILLIPS
GREGORY B. PHILLIPS KNOBBE, MARTENS, OLSON & BEAR, LLP2040 MAIN STREET, 14TH FLOORIRVINE, CA 92614United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Radio frequency identification (RFID) tags; RFID scanning readers for tracking and taking inventory of pharmaceuticals, medical supplies, and medical devices; Bar code Printers; Electronic database recorded on computer media containing pharmaceutical, medical, healthcare, and life sciences information; Electronic database recorded on computer media containing pharmaceutical, medical, healthcare, and life sciences information | ACTIVE | Apr 19, 2019 |
| 035 | Electronic data collection, management, and analysis services for business purposes, namely, in the fields of medicine, healthcare, pharmaceuticals, and biotechnology; Business services provided to the medical, healthcare, pharmaceutical, and biotechnology industries, namely, the collection, reporting, and analysis of healthcare and pharmaceutical quality data for business purposes | ACTIVE | — |
| 042 | Creating and assigning identification numbers and radio frequency identification (RFID) tags for use with an authentication and verification service for pharmaceuticals, medication dispensing systems, and medical supplies; Data warehousing in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Testing, analysis, and evaluation of the goods of others namely, pharmaceuticals, medical records, medication dispensing systems, and medical supplies, and related services, to assure compliance with industry standards; Developing quality control standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Developing quality control standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Developing quality control standards in connection with tracking, auditing, assessing, reviewing, and reporting data found in medical records and medication dispensing systems; Developing quality control standards in connection with assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Developing quality control standards in connection with supply chain management and inventory management systems for pharmaceuticals and medical supplies; Developing quality control standards in connection with implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Developing and maintaining an on-line database for others consisting of a registry of approved identification numbers for use with an authentication and verification service for pharmaceuticals, medication dispensing systems, and medical supplies; Developing and maintaining an on-line database for others consisting of a registry of data regarding the manufacture, inspection, regulatory compliance, supply, distribution, attributes, and sale of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Providing temporary use of non-downloadable computer software for supply chain management of pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for monitoring purchasing trends and pricing for pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding cost-effective alternatives, alternative suppliers, and products in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding alternatives to help alleviate or respond to pharmaceutical, vaccine and medication shortages; Providing temporary use of non-downloadable computer software for providing information and recommendations regarding compliance with contracts, discount programs, and rebates in connection with purchasing pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records, namely in connection with purchase pricing, budgeting, discounts, and rebates; Providing temporary use of non-downloadable computer software for assessing, reviewing, and auditing prescription and medication records in connection with contract compliance and Group Purchasing Organizations (GPO) compliance; Providing temporary use of non-downloadable computer software for assessing, reviewing and reporting data trends found in prescription and medication records; Providing temporary use of non-downloadable computer software for monitoring, tracking, and taking inventory of pharmaceuticals, vaccines, and medications; Providing temporary use of non-downloadable computer software for tracking pharmaceuticals and medical supplies, namely collecting, organizing, disseminating, creating analytic and statistic models, and reporting data regarding the manufacture, inspection, regulatory compliance, supply, distribution, attributes, and sale of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for tracking pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for dispensing and administering pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for collecting, organizing, disseminating, creating analytic and statistic models, and reporting data contained in electronic medical records, pharmaceutical purchasing systems, supply chain management systems, inventory management systems, pharmaceutical manufacturing systems, pharmaceutical regulatory systems, and pharmaceutical compliance and surveillance systems; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems; Providing temporary use of non-downloadable computer software for use in data collection, data management and data analysis of pharmaceutical, medical, healthcare, and life sciences information; Providing temporary use of non-downloadable computer software for collecting, managing, analyzing, and displaying data and information in the pharmaceutical, medical, healthcare and life sciences fields; Providing temporary use of non-downloadable computer software for collecting, managing, analyzing, and displaying data related to patient registries, quality improvement, patient support, and patient management in the pharmaceutical, medical, healthcare, and life sciences fields; Providing temporary use of non-downloadable computer software for collecting, managing, analyzing, and displaying data related to tracking and taking inventory of pharmaceuticals and medical supplies; Providing temporary use of non-downloadable computer software for collecting, managing, analyzing, and displaying data related to auditing medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for tracking and taking inventory of pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for auditing medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for reporting data in medical records and medication dispensing systems; Software as a service (SAAS) services featuring software for assessing and reviewing data in medical records and medication dispensing systems to formulate a discrepancy resolution process; Software as a service (SAAS) services featuring software for tracking pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for dispensing pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for administering pharmaceuticals; Software as a service (SAAS) services featuring software for collecting, organizing, disseminating, creating analytic and statistic models, and reporting data contained in electronic medical records, pharmaceutical purchasing systems, supply chain management systems, inventory management systems, pharmaceutical manufacturing systems, pharmaceutical regulatory systems, and pharmaceutical compliance and surveillance systems; Software as a service (SAAS) services featuring software for implementing industry standards in connection with pharmaceuticals, medical records, medication dispensing systems, and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, dispensing, and taking inventory of pharmaceuticals and medical supplies; Software as a service (SAAS) services featuring software for implementing industry standards in connection with tracking, auditing, assessing, reviewing, and reporting data in medical records and medication dispensing systems | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BLUESIGHT, INC.
- Other trademarks owned by Kit Check, Inc.
- Other trademarks owned by BLUESIGHT, INC.
- Other trademarks owned by BLUESIGHT, INC.
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named BLUESIGHT
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 23, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 23, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 1, 2026 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jun 1, 2026 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| May 20, 2026 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 14, 2026 | IUAF | USE AMENDMENT FILED | — |
| Jan 14, 2026 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jul 12, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jul 11, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 11, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 11, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 11, 2025 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jul 11, 2025 | EXT2 | SOU EXTENSION 2 FILED | — |
| Jul 11, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2025 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 13, 2025 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 13, 2025 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jan 13, 2025 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 16, 2024 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 7, 2024 | TMBN | TTAB RELEASE CASE TO TRADEMARKS | — |
| Jun 7, 2024 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Jun 7, 2024 | OP.D | OPPOSITION DISMISSED NO. 999999 | — |
| May 7, 2024 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| May 7, 2024 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Dec 6, 2023 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Nov 7, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 7, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 18, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 2, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 6, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 5, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 5, 2023 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jul 26, 2023 | ASCK | ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | — |
| Jun 5, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jun 5, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 5, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 13, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 12, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 12, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 3, 2023 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 13, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 13, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 23, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 10, 2022 | NWAP | NEW APPLICATION ENTERED | — |